Physician
Basiratmand, Siamak
Basiratmand, Siamak was paid $0.00 by Medicaid between Sep 2019 and Dec 2024, across 42 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 0% of everything it billed.
33Billing provider infoBASIRATMAND, SIAMAK
VALENCIA, CA 91355
VALENCIA, CA 91355
33aNPI1225165731assigned 02/28/2007
33bProvider typeInternal Medicine Physician
28Total paid$0.00
24GClaims26,165
24DCodes billed42
24AFirst – last monthSep 2019 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#2,431 of 2,679
Median peer was paid$13K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 115 | $0.00 | |
| 2020 | 2,979 | $0.00 | |
| 2021 | 5,584 | $0.00 | |
| 2022 | 4,856 | $0.00 | |
| 2023 | 5,572 | $0.00 | |
| 2024incomplete | 7,059 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 0% | 5,053 | 4,511 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,773 | 1,633 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 409 | 403 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 26 | 25 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 2,327 | 2,178 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 148 | 148 | $0.00 |
| 86780 | 0% | 214 | 213 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 685 | 680 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 2,645 | 2,626 | $0.00 |
| 3080F | 0% | 13 | 12 | $0.00 | |
| 3074F | 0% | 439 | 413 | $0.00 | |
| 81001 | 0% | 39 | 38 | $0.00 |
30 more codes
| 82043 | 0% | 458 | $0.00 | |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 1,290 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 330 | $0.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 954 | $0.00 |
| 87522 | Neg quan hep c or qual rna | 0% | 304 | $0.00 |
| 85027 | 0% | 569 | $0.00 | |
| 82607 | 0% | 42 | $0.00 | |
| 1111F | 0% | 138 | $0.00 | |
| 3075F | 0% | 115 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 27 | $0.00 |
| 99443 | 0% | 170 | $0.00 | |
| 3079F | 0% | 81 | $0.00 | |
| 3044F | 0% | 283 | $0.00 | |
| 86592 | 0% | 62 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 25 | $0.00 |
| 99441 | 0% | 13 | $0.00 | |
| 80061 | Lipid panel | 0% | 2,258 | $0.00 |
| 3077F | 0% | 101 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 2,457 | $0.00 |
| 82274 | 0% | 243 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 148 | $0.00 |
| 86703 | 0% | 832 | $0.00 | |
| 82540 | 0% | 458 | $0.00 | |
| 99442 | 0% | 313 | $0.00 | |
| 3078F | 0% | 527 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 44 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 27 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 66 | $0.00 |
| 77062 | 0% | 31 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.